Description
GLYSIT-MET 5/500 mg Tablets – 30’s
GLYSIT-MET 5/500 mg Tablets are a fixed-dose combination of Empagliflozin (5 mg) and Metformin Hydrochloride (500 mg), formulated to provide effective dual therapy for the management of type 2 diabetes mellitus. This combination targets multiple pathways to help lower blood glucose levels while offering additional metabolic and cardiovascular benefits.
Empagliflozin, an SGLT2 inhibitor, reduces glucose reabsorption in the kidneys, promoting its excretion through urine. Metformin, a biguanide, works by decreasing hepatic glucose production and improving insulin sensitivity. Together, they enhance glycemic control with a low risk of hypoglycemia and may aid in weight loss.
This formulation is ideal for patients who require a lower Metformin dose or are initiating combination therapy. The 30-tablet pack supports once or twice-daily dosing, depending on clinical needs.
Key Features:
-
Contains Empagliflozin 5 mg + Metformin 500 mg
-
Dual mechanism: improves insulin sensitivity and enhances glucose excretion
-
Supports fasting and postprandial blood glucose control
-
Low risk of hypoglycemia and may assist with weight reduction
-
Provides added cardiovascular and renal protection
-
30 tablets per pack for a one-month supply
Usage:
Take as prescribed by your physician, preferably with meals to reduce gastrointestinal discomfort. Monitor blood glucose and kidney function regularly.
Reviews
There are no reviews yet.